7.735
4.74%
0.345
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
Cantor Fitzgerald Weighs in on Kura Oncology FY2025 Earnings - MarketBeat
Assenagon Asset Management S.A. Sells 146,879 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - MarketBeat
Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 17.4% in December - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Harbor Capital Advisors Inc. Boosts Holdings in Kura Oncology, Inc. (NASDAQ:KURA) - Defense World
Kura Oncology secures new headquarters in San Diego - Investing.com India
Kura Oncology secures new headquarters in San Diego By Investing.com - Investing.com Australia
Kura Oncology stock hits 52-week low at $8.38 amid market challenges - Investing.com Nigeria
Kura Oncology (NASDAQ:KURA) Sets New 12-Month LowTime to Sell? - MarketBeat
Brokers Set Expectations for Kura Oncology FY2029 Earnings - Defense World
Brokers Offer Predictions for Kura Oncology FY2029 Earnings - MarketBeat
BlackRock, Inc. Increases Stake in Kura Oncology Inc - GuruFocus.com
Long Term Trading Analysis for (KURA) - Stock Traders Daily
Scotiabank Cuts Kura Oncology (NASDAQ:KURA) Price Target to $10.00 - MarketBeat
Kura Oncology announces executive changes and settlement By Investing.com - Investing.com Australia
Kura Oncology announces executive changes and settlement - Investing.com India
Kura Oncology appoints new CMO and CSO By Investing.com - Investing.com Australia
Kura Oncology (NASDAQ:KURA) Sets New 1-Year LowTime to Sell? - MarketBeat
Kura Oncology Announces Leadership Changes and Appointments - MSN
Kura Oncology Promotes New Chief Medical Officer - MarketWatch
Kura Oncology appoints new CMO and CSO - Investing.com
Kura Oncology Announces Senior Executive Promotions - The Manila Times
Kura Oncology (NASDAQ:KURA) Hits New 12-Month LowHere's Why - MarketBeat
Kura Crashes 37% After $1.53 Billion Deal Slams The Door On A Takeover - MSN
Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Kura Oncology, Inc. (NASDAQ:KURA) Given Average Recommendation of “Buy” by Analysts - Defense World
Objective long/short (KURA) Report - Stock Traders Daily
Kura Oncology (NASDAQ:KURA) Sets New 12-Month Low – Here’s What Happened - Defense World
Kura Oncology's Stock Sinks To US$8.94, But Insiders Sold Even Lower - Simply Wall St
Kura Oncology (NASDAQ:KURA) Reaches New 12-Month LowWhat's Next? - MarketBeat
Kura Oncology stock hits 52-week low at $8.83 amid market challenges - Investing.com Australia
Kura Oncology expands stock option plan - Investing.com India
Kura Oncology expands stock option plan By Investing.com - Investing.com UK
Kura Oncology (NASDAQ:KURA) Reaches New 52-Week LowWhat's Next? - MarketBeat
Kura Oncology Presents Deep Value At Today's Prices (Rating Upgrade) (NASDAQ:KURA) - Seeking Alpha
(KURA) Proactive Strategies - Stock Traders Daily
Kura, Kyowa highlight positive combo data for ziftomenib - BioWorld Online
Kura Oncology's SWOT analysis: ziftomenib's promise buoys stock outlook By Investing.com - Investing.com UK
Kura Oncology's SWOT analysis: ziftomenib's promise drives stock outlook By Investing.com - Investing.com South Africa
Kura Oncology's SWOT analysis: ziftomenib's promise drives stock outlook - Investing.com India
Kura Oncology's SWOT analysis: ziftomenib's potential reshapes cancer stock landscape - Investing.com Canada
Kura Oncology’s (KURA) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):